#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Athero Review - Issue 2/2022

Editorial

63

Reviews

67

Lysosomal acid lipase deficiency – differential diagnosis and treatment options in 2022

Zuzana Urbanová, Věra Malinová, Tomáš Freiberger, Lukáš Tichý, Michal Vrablík

71

Lifelong exposure and trajectories of the risk factors – a new direction in prediction of CVD risk

Jaroslav A. Hubáček

76

Cancer treatment as a non-traditional risk factor for atherosclerosis

Pavel Kraml

82

Impact of SGLT2 inhibitors on cardiovascular disease

Hana Rosolová

85

Benefits of GLP-1 receptor agonists therapy for patients with cardiovascular disease

Martin Haluzík, Michal Vrablík

91

Characteristics of the Czech cohort of patients with familial dysbetalipoproteinemia and evaluation of the applicability of diagnostic algorithms in clinical practice

Martin Šatný, Tereza Altschmiedová, Veronika Todorovová, Ondřej Kyselák, Vladimír Soška, Michal Vrablík

100

GLP-1 receptor agonists and atherosclerosis

Branislav Vohnout, Jana Lisičanová

104

Fats in food pyramids and plates

Jiří Brát

Clinical Studies

110

How are we doing in achieving target LDL-cholesterol levels in the high-risk population in Slovakia: retrospective study

Štefan Tóth, Daniel Pella

From International Literature

116

Research on remarkable articles from international literature

Eva Tůmová

Announcements

118

25. kongres o ateroskleróze – opět virtuální, opět dobrý

Kristýna Čillíková

Athero Review

Issue 2

2022 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#